Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells

Toxicol In Vitro. 2011 Apr;25(3):692-8. doi: 10.1016/j.tiv.2011.01.010. Epub 2011 Jan 23.

Abstract

The accumulation of misfolded proteins in the lumen of the endoplasmic reticulum (ER) results in cellular stress that initiates a specialized response designated as the unfolded protein response. ER stress has been implicated in a variety of common diseases, such as diabetes, ischemia and neurodegenerative disorders. Withaferin A, a major chemical constituent of Withania somnifera, has been reported to inhibit tumor cell growth. We show that withaferin A induced a dose-dependent apoptotic cell death in several types of human cancer cells, as measured by FACS analysis and PARP cleavage. Treatment of Caki cells with withaferin A induced a number of signature ER stress markers, including phosphorylation of eukaryotic initiation factor-2α (eIF-2 α), ER stress-specific XBP1 splicing, and up-regulation of glucose-regulated protein (GRP)-78. In addition, withaferin A caused up-regulation of CAAT/enhancer-binding protein-homologous protein (CHOP), suggesting the induction of ER stress. Pretreatment with N-acetyl cysteine (NAC) significantly inhibited withaferin A-mediated ER stress proteins and cell death, suggesting that reactive oxygen species (ROS) mediate withaferin A-induced ER stress. Furthermore, CHOP siRNA or inhibition of caspase-4 activity attenuated withaferin A-induced apoptosis. Taken together, the present study provides strong evidence supporting an important role of the ER stress response in mediating withaferin A-induced apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / metabolism
  • Carcinoma, Renal Cell / pathology
  • Cell Nucleus
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Endoplasmic Reticulum, Rough / drug effects*
  • Endoplasmic Reticulum, Rough / metabolism
  • Gene Silencing
  • HT29 Cells
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / metabolism
  • Kidney Neoplasms / pathology
  • Oxidative Stress / drug effects*
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / genetics
  • Regulatory Factor X Transcription Factors
  • Transcription Factor CHOP / genetics
  • Transcription Factor CHOP / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Withanolides / pharmacology*
  • X-Box Binding Protein 1

Substances

  • Antineoplastic Agents
  • DDIT3 protein, human
  • DNA-Binding Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • Regulatory Factor X Transcription Factors
  • Transcription Factors
  • Withanolides
  • X-Box Binding Protein 1
  • XBP1 protein, human
  • Transcription Factor CHOP
  • withaferin A